Related Experiment Video
Updated: May 15, 2026

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
The marine polyketide myriaporone 3/4 stalls translation by targeting the elongation phase
Yazh Muthukumar1, Myriam Roy, Aruna Raja
1Department of Chemical Biology, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany.
Abstract:
Myriaporone 3/4, a cytotoxic polyketide, has been reported as an inhibitor of eukaryotic protein synthesis. However, the mechanism by which it inhibits translation was unknown. Here we show that myriaporone 3/4 stalls protein synthesis in the elongation phase by inducing phosphorylation of eukaryotic elongation factor 2. The phosphorylation results from direct binding of myriaporone 3/4 to eukaryotic elongation factor 2 kinase. Our study also shows that myriaporone 3/4 in the nanomolar range inhibits in vitro tube formation by endothelial cells without being cytotoxic. In general, myriaporone 3/4 was at least 300 times less toxic to primary cells than to tumor cells.
Insights
Myriaporone 3/4 inhibits eukaryotic protein synthesis by stalling translation elongation. This occurs through direct binding to eukaryotic elongation factor 2 kinase, leading to factor 2 phosphorylation and reduced endothelial cell tube formation.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Biology
Background:
- Myriaporone 3/4 is a known cytotoxic polyketide.
- Its role as an inhibitor of eukaryotic protein synthesis has been documented.
- The precise mechanism of translation inhibition by myriaporone 3/4 remained unclear.
Purpose of the Study:
- To elucidate the mechanism by which myriaporone 3/4 inhibits eukaryotic protein synthesis.
- To investigate the effect of myriaporone 3/4 on endothelial cell function.
- To assess the differential toxicity of myriaporone 3/4 in various cell types.
Main Methods:
- Investigated the effect of myriaporone 3/4 on protein synthesis elongation.
- Examined the phosphorylation status of eukaryotic elongation factor 2 (eEF2).
- Assessed the binding of myriaporone 3/4 to eukaryotic elongation factor 2 kinase (eEF2K).
- Evaluated the impact of myriaporone 3/4 on in vitro endothelial cell tube formation.
- Compared the cytotoxicity of myriaporone 3/4 in primary and tumor cells.
Main Results:
- Myriaporone 3/4 was found to stall protein synthesis during the elongation phase.
- This stalling is mediated by the induction of eEF2 phosphorylation.
- Myriaporone 3/4 directly binds to eEF2K, causing the observed phosphorylation.
- Inhibition of in vitro endothelial cell tube formation was observed at nanomolar concentrations.
- Myriaporone 3/4 exhibited significantly lower toxicity towards primary cells compared to tumor cells (at least 300-fold difference).
Conclusions:
- Myriaporone 3/4 inhibits eukaryotic translation by targeting the eEF2K-eEF2 pathway.
- The compound demonstrates anti-angiogenic potential by inhibiting endothelial cell tube formation at low, non-cytotoxic concentrations.
- Myriaporone 3/4 displays a favorable therapeutic window due to its selective toxicity towards tumor cells over primary cells.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Translation in Prokaryotes
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Termination of Translation
Inhibitors of Gram-positive Cell Wall Synthesis

